Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OFIX 
Orthofix Medical Inc (OFIX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: OFIX (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.55
1 Year Target Price $22.55
| 2 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -57.62% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 586.09M USD | Price to earnings Ratio - | 1Y Target Price 22.55 |
Price to earnings Ratio - | 1Y Target Price 22.55 | ||
Volume (30-day avg) 5 | Beta 0.82 | 52 Weeks Range 10.24 - 20.73 | Updated Date 08/28/2025 |
52 Weeks Range 10.24 - 20.73 | Updated Date 08/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-05 | When - | Estimate -0.41 | Actual -0.36 |
Profitability
Profit Margin -15.29% | Operating Margin (TTM) -8.25% |
Management Effectiveness
Return on Assets (TTM) -5.95% | Return on Equity (TTM) -24.64% |
Valuation
Trailing PE - | Forward PE 20.04 | Enterprise Value 721277466 | Price to Sales(TTM) 0.72 |
Enterprise Value 721277466 | Price to Sales(TTM) 0.72 | ||
Enterprise Value to Revenue 0.89 | Enterprise Value to EBITDA 195.84 | Shares Outstanding 39494300 | Shares Floating 39008486 |
Shares Outstanding 39494300 | Shares Floating 39008486 | ||
Percent Insiders 2.76 | Percent Institutions 91.88 |
Upturn AI SWOT
Orthofix Medical Inc
Company Overview
History and Background
Orthofix Medical Inc. was founded in 1980. Initially focused on external fixation, it has evolved through acquisitions and internal development to offer a broader portfolio of orthopedic and spine solutions. Key milestones include strategic acquisitions expanding its product lines and geographic reach.
Core Business Areas
- Spine Fixation: Offers a range of implants and technologies for spinal fusion and non-fusion procedures, addressing degenerative conditions, trauma, and deformities.
- Biologics: Develops and markets bone growth stimulation devices and allografts to enhance bone healing in orthopedic and spine surgeries.
- Extremity Fixation: Provides external fixation systems for fracture management, limb lengthening, and reconstruction procedures, targeting both trauma and elective cases.
- Bone Growth Therapies: This includes stimulators that promote healing for nonunions and other bone-related issues.
Leadership and Structure
The leadership team includes the CEO, CFO, and other key executives responsible for different business segments and functions. The organizational structure typically involves departments such as sales, marketing, R&D, operations, and finance, with regional teams to support global operations.
Top Products and Market Share
Key Offerings
- FORZA XP Expandable Interbody System: A spinal fusion implant. Competitors include Medtronic (MDT) and Nuvasive (NUVA). No specific market share for this particular product available but expandable interbody devices are a significant part of the spinal fusion market estimated to be approximately $2.0 billion worldwide.
- Physio-Stim: Bone growth stimulation device designed to enhance bone healing. Competitors include Zimmer Biomet (ZBH) and Bioventus (BVS). The market for bone growth stimulation is estimated to be several hundred million USD annually, with Physio-Stim being a key player.
- TRUE LOK: External Fixation. Competitors include Stryker (SYK) and Smith & Nephew (SNN). The extremity fixation market is fragmented, and TRUE LOK is one of several such external fixation systems.
Market Dynamics
Industry Overview
The orthopedic and spine market is driven by an aging population, increasing prevalence of musculoskeletal disorders, and technological advancements. The industry is competitive, with established players and emerging companies vying for market share. Regulatory requirements and reimbursement policies significantly influence market access and adoption of new technologies.
Positioning
Orthofix Medical Inc. holds a mid-tier position within the orthopedic and spine market. Its competitive advantages include a diverse product portfolio, established distribution network, and focus on innovation. However, it faces competition from larger players with greater resources and market presence.
Total Addressable Market (TAM)
The global orthopedic devices market is expected to reach over $60 billion. Orthofix targets specific segments like spine and bone growth stimulation, positioning them to capture a share within those specific areas. The exact share they can capture will depend on strategic initiatives and competitive pressures.
Upturn SWOT Analysis
Strengths
- Diverse product portfolio
- Established distribution network
- Focus on innovation
- Strong brand recognition in specific segments
- Experienced management team
Weaknesses
- Smaller market share compared to industry leaders
- Reliance on specific product lines
- Potential impact from regulatory changes
- Limited R&D budget compared to larger competitors
- High debt levels
Opportunities
- Expanding into emerging markets
- Developing new technologies
- Acquiring complementary businesses
- Increasing adoption of minimally invasive procedures
- Capitalizing on demographic trends
Threats
- Intense competition
- Pricing pressures
- Product liability lawsuits
- Changes in reimbursement policies
- Economic downturns
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- ZBH
- STRYKER
- NUVA
Competitive Landscape
Orthofix Medical Inc. operates in a competitive landscape, needing to innovate to grow against its competitors with greater market shares.
Major Acquisitions
SeaSpine
- Year: 2023
- Acquisition Price (USD millions): 420
- Strategic Rationale: To expand spine and orthopedic offerings, increase market share, and improve long-term growth. Provides enhanced financial flexibility.
Growth Trajectory and Initiatives
Historical Growth: Orthofix's historical growth has been a mix of organic growth and acquisitions. Please look into historical annual reports for a detailed growth trend
Future Projections: Future projections require real-time access to analyst ratings which cannot be accessed through this medium
Recent Initiatives: Recent initiatives include new product launches, strategic partnerships, and cost-saving measures. More details may be available from latest press releases or quarterly earnings calls.
Summary
Orthofix Medical Inc. is a mid-sized player in the orthopedic and spine market. Its acquisition of SeaSpine will expand its portfolio, however, it still faces significant competition from industry leaders. The company's focus on innovation and strategic acquisitions is vital for its future success and long-term growth, however high debt and pricing pressure pose a risk.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company reports
- Analyst reports
- Industry publications
- Market research reports
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It should not be considered financial advice. Market share and TAM data are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthofix Medical Inc
Exchange NASDAQ | Headquaters Lewisville, TX, United States | ||
IPO Launch date 1992-04-24 | President, CEO & Director Mr. Massimo Calafiore | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1616 | Website https://orthofix.com |
Full time employees 1616 | Website https://orthofix.com | ||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.